Special concerns in defining, studying, and treating dystonia in children

Movement Disorders

Volumn 28, Issue 7, 2013, Pages 921-925

  Mink, Jonathan W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Development; Pediatrics; Rating scales; Treatment

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CARBIDOPA PLUS LEVODOPA; TRIHEXYPHENIDYL;

BARRY ALBRIGHT DYSTONIA SCALE; BRAIN DEPTH STIMULATION; BURKE FAHN MARSDEN DYSTONIA RATING SCALE; CHILDHOOD DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DYSTONIA; HUMAN; MEDICAL TERMINOLOGY; MOTOR DYSFUNCTION; MOVEMENT DISORDER CHILDHOOD RATING SCALE; MUSCLE HYPERTONIA; NERVOUS SYSTEM DEVELOPMENT; ONSET AGE; PRIORITY JOURNAL; RATING SCALE; REVIEW; SYMPTOMATOLOGY;

EID: 84880845637     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25548     Document Type: Review

References (29)

1. Oppenheim H. Uber eine eigneartige Krampfkrankheit des kindlichen un jugendlichen Alters (Dysbasia lordotica progressiva, dystona musculorum deformans). Neurologishe Centralblatt 1911;30:1080-1107.
2. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-873.
3. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, eds. Movement Disorders 2. London, United Kingdom: Butterworth; 1987:332-358.
4. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood [serial online]. Pediatrics 2003;111:e89-e97.
5. Sanger TD, Chen D, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Definition and classification of negative motor signs in childhood. Pediatrics 2006;118:2159-2167.
6. Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord 2010;25:1538-1549.
7. Jethwa A, Mink J, Macarthur C, Knights S, Fehlings T, Fehlings D. Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children [serial online]. Devel Med Child Neurol 2010;52:e83-e87.
8. Gordon LM, Keller JL, Stashinko EE, Hoon AH, Bastian AJ. Can spasticity and dystonia be independently measured in cerebral palsy? Pediatr Neurol 2006;35:375-381.
9. Volpe J. Neurology of the Newborn. 3rd ed. Philadelphia, PA: WB Saunders; 1995.
10. Camp JA, Bialer I, Press M, Winsberg BG. The physical and neurological examination for soft signs (PANESS): pediatric norms and comparisons between normal and deviant boys [proceedings]. Psychopharmacol Bull 1977;13:39-41.
11. Ouvrier R, Billson F. Paroxysmal tonic upgaze of childhood-a review. Brain Dev 2005;27:185-188.
12. Al-Twaijri W, Shevell M. Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr Neurol 2002;26:365-368.
13. Deonna T, Ziegler A, Nielsen J. Transient idiopathic dystonia in infancy. Neuropediatrics 1991;22:220-224.
14. Kotagal P, Costa M, Wyllie E, Wolgamuth B. Paroxysmal nonepileptic events in children and adolescents [serial online]. Pediatrics 2002;110:e46.
15. Collins A, Jankovic J. Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology 2006;67:1083-1085.
16. Ballock RT, Song KM. The prevalence of nonmuscular causes of torticollis in children. J Pediatr Orthop 1996;16:500-504.
17. Yang ML, Fullwood E, Goldstein J, Mink JW. Masturbation in infancy and early childhood presenting as a movement disorder: 12 cases and a review of the literature. Pediatrics 2005;116:1427-1432.
18. Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003;18:303-312.
19. Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol 1999;41:404-411.
20. Battini R, Guzzetta A, Sgandurra G, et al. Scale for evaluation of movement disorders in the first three years of life. Pediatr Neurol 2009;40:258-264.
21. Battini R, Sgandurra G, Petacchi E, et al. Movement disorder-childhood rating scale: reliability and validity. Pediatr Neurol 2008;39:259-265.
22. Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986;36:160-164.
23. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985;35:73-77.
24. Mink JW. Dystonia (DRD, primary, secondary). In: Singer HS, Kossoff EH, Hartman AL, Crawford TO, eds. Treatment of Pediatric Neurologic Disorders. Boca Raton, FL: Taylor & Francis; 2005:139-144.
25. Cialone J, Mink J. Globus pallidus deep brain stimulation provides benefit and allows medication reduction in young children. Dev Med Child Neurol 2012;54(suppl 4):39-40.
26. Haridas A, Tagliati M, Osborn I, et al. Pallidal deep brain stimulation for primary dystonia in children. Neurosurg 2011;68:738-743; discussion 743.
27. Gimeno H, Lumsden D, Gordon A, Tustin K, Ashkan K, Selway R, Lin JP. Improvement in upper limb function in children with dystonia following deep brain stimulation [published online ahead of print 16 January 2013]. Eur J Paediatr Neurol 2013.
28. Gimeno H, Tustin K, Selway R, Lin JP. Beyond the Burke-Fahn-Marsden Dystonia Rating Scale: deep brain stimulation in childhood secondary dystonia. Eur J Paediatr Neurol 2012;16:501-508.
29. Sanger TD, Bastian A, Brunstrom J, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007;22:530-537.